외상 고정 장치 : 시장 점유율 분석, 산업 동향, 통계, 성장 예측(2025-2030년)

The trauma fixation devices market size is currently valued at USD 7.94 billion in 2025 and is forecast to reach USD 10.89 billion by 2030, expanding at a 6.51% CAGR over 2025-2030.

Internal innovation in bioabsorbable metals, rapid adoption of drug-eluting plates and screws, and the growing preference for outpatient fracture care are the three strongest forces sustaining this momentum. Demographic pressures from osteoporosis, population ageing, and higher accident exposure in urban centers are widening the patient pool, while value-based reimbursement is shifting hospital purchasing toward implants that shorten length of stay and avert secondary removal surgery. Supply-chain risk in titanium and nitinol continues to create margin pressure but is simultaneously nudging manufacturers to explore novel alloy chemistries. Competitive strategies center on 3D-printed patient-specific hardware, antimicrobial coatings, and integrated digital surgery platforms that improve procedural speed and accuracy.

Global Trauma Fixation Devices Market Trends and Insights

Rising Prevalence of Bone-Degenerative Diseases & Osteoporosis

Global osteoporosis affects an estimated 500 million people and is reshaping demand for fixation solutions tailored to compromised bone quality. Fragility fractures now drive hospital admissions that once stemmed from high-energy trauma, prompting device makers to integrate bone-building pharmaceuticals directly into screws and plates. Health systems in the United States incur annual fracture costs above USD 25 billion, forcing payers to fund preventive implants that avert refracture. Manufacturers are therefore racing to validate bioactive constructs that strengthen osseointegration while gradually off-loading stress to healing bone. The trend is most visible in North America and Europe where aging curves are steepest and reimbursement supports premium implants. Over the long term, this driver is expected to add 1.2 percentage points to the trauma fixation devices market CAGR.

Increasing Incidence of Road Traffic Accidents & Trauma Injuries

WHO records show injuries claim 4.4 million lives each year, with Asia-Pacific bearing the heaviest load as motorization outpaces safety infrastructure. Expanding urban sports cultures and industrial workplaces add further fracture complexity, demanding modular fixation systems capable of stabilizing multiple bones in a single session. Device makers are introducing integrated platforms that cut operating time and streamline inventory. In medium-term horizons, rising trauma exposure in India, China, and Southeast Asia injects 0.8 percentage points into the projected CAGR for the trauma fixation devices market.

High Procedure & Device Costs

Premium bioabsorbable and drug-eluting implants cost more up front, limiting uptake in lower-income settings. Bundled payments push hospitals and ambulatory centers to scrutinize total episode cost, often opting for modular systems that stretch inventory budgets. This cost friction shaves 0.7 percentage points off short-term trauma fixation devices market growth.

Other drivers and restraints analyzed in the detailed report include:

1. Growing Geriatric Population Vulnerable to Fractures
2. Technological Advances in Bio-Compatible & Bio-Absorbable Fixation Materials
3. Rising Implant-Associated MDR-Infection Concerns

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Internal fixators generated 64.51% of trauma fixation devices market share in 2024, while their sub-segment is set to log an 8.25% CAGR to 2030, the fastest across all device categories. The trauma fixation devices market size attributed to internal fixators will thus outpace overall industry expansion as bioabsorbable screws gain traction in pediatrics and geriatrics. Plates equipped with dynamic compression slots permit controlled micromotion that encourages callus formation; Zimmer Biomet's MotionLoc screw exemplifies this capability.

The advent of smart alloys and modular tray layouts lets surgeons adjust construct stiffness intraoperatively, cutting inventory by up to 30%. Drug-eluting coatings further differentiate internal hardware by merging mechanical support with biologic therapy. External fixators remain indispensable for complex open fractures and damage-control orthopedics, yet reimbursement pressures drive interest toward reusable frame kits that lower per-case expenditure. Together, these trends keep internal solutions ahead but invite continuous innovation to protect share.

The Trauma Fixation Devices Market Report is Segmented by Device Type (Internal Fixators [Plates, Screws, and More], External Fixators [Unilateral & Bilateral Fixators, and More]), Surgical Site (Lower Extremities [Hip & Pelvic, and More], and Upper Extremities), End User (Hospitals, Ambulatory Surgery Centers, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Geography Analysis

North America controlled 39.32% of global revenue in 2024 and will maintain its lead through 2030 on the back of robust reimbursement and high surgical skill density. The November 2024 FDA guidance for bone plates and screws has sharpened review criteria yet also clarified pathways, shortening approval cycles for digital-ready implants. United States payers actively fund bioabsorbable implants to dodge secondary surgery, while Canadian hospitals invest in robotics aimed at smaller incisions and quicker turnover.

Asia-Pacific is forecast to clock the fastest 7.71% CAGR over 2025-2030 as healthcare systems expand orthopedic theaters and trauma centers. China and India witness rapid trauma growth tied to urban transportation and construction, prompting procurement of versatile modular fixators. Japan's super-aged society pushes geriatric-specific nailing systems, whereas South Korea pioneers AI-driven fracture planning. Domestic OEMs in China are entering global supply chains for titanium plates, adding competitive heat.

Europe remains a stable third pillar, buffered by tight CE-Mark scrutiny and strong clinician-industry collaboration. Germany and the United Kingdom spearhead biodegradable implant trials aligned with environmental directives. Southern European markets accelerate adoption of reuse-optimized external fixators to curb spending. In Central-Eastern Europe, EU structural funds upgrade trauma units, giving multinationals fresh tenders.

The Middle East and Africa, alongside South America, collectively offer mid-single-digit expansion as governments channel oil proceeds and recovery funds into tertiary hospitals. Gulf states buy premium navigation-enabled systems, whereas Sub-Saharan Africa leans on donor-funded fracture programs that seek reusable ex-fix frames. Across Latin America, Brazil's public health service increasingly reimburses drug-eluting plates for diabetic foot fracture prevention, nudging regional procurement norms higher.

1. Arthrex
2. B. Braun
3. Cardinal Health
4. Conmed
5. Johnson & Johnson
6. Orthofix
7. Medtronic
8. Smiths Group
9. Stryker
10. Zimmer Biomet
11. Invibio
12. Globus Medical
13. Acumed
14. Wright Medical Group
15. NuVasive
16. MicroPort
17. OsteoMed LLC
18. Integra LifeSciences Holdings Corp.
19. Bio-Medical Enterprises Inc.
20. Orthopaedic Implant Company

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Prevalence Of Bone-Degenerative Diseases & Osteoporosis
  • 4.2.2 Increasing Incidence Of Road Traffic Accidents & Trauma Injuries
  • 4.2.3 Growing Geriatric Population Vulnerable To Fractures
  • 4.2.4 Technological Advances In Bio-Compatible & Bio-Absorbable Fixation Materials
  • 4.2.5 Orthobiologic-Enhanced Fixation (Drug-Eluting Plates / Screws)
  • 4.2.6 Value-Based Procurement Driving Modular Reusable External Fixators In EMs
• 4.3 Market Restraints
  • 4.3.1 High Procedure & Device Costs
  • 4.3.2 Stringent & Time-Consuming Regulatory Approvals
  • 4.3.3 Supply-Chain Risk For Medical-Grade Ti & Nitinol Alloys
  • 4.3.4 Rising Implant-Associated MDR-Infection Concerns
• 4.4 Technological Outlook
• 4.5 Porter's Five Forces
  • 4.5.1 Bargaining Power of Buyers
  • 4.5.2 Bargaining Power of Suppliers
  • 4.5.3 Threat of New Entrants
  • 4.5.4 Threat of Substitutes
  • 4.5.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Device Type
  • 5.1.1 Internal Fixators
    • 5.1.1.1 Plates
    • 5.1.1.2 Screws
    • 5.1.1.3 Nails
    • 5.1.1.4 Others
  • 5.1.2 External Fixators
    • 5.1.2.1 Unilateral & Bilateral Fixators
    • 5.1.2.2 Circular Fixators
    • 5.1.2.3 Hybrid Fixators
• 5.2 By Surgical Site
  • 5.2.1 Lower Extremities
    • 5.2.1.1 Hip & Pelvic
    • 5.2.1.2 Foot & Ankle
    • 5.2.1.3 Knee
    • 5.2.1.4 Others
  • 5.2.2 Upper Extremities
    • 5.2.2.1 Hand & Wrist
    • 5.2.2.2 Shoulder
    • 5.2.2.3 Spine
    • 5.2.2.4 Others
• 5.3 By End User
  • 5.3.1 Hospitals
  • 5.3.2 Ambulatory Surgery Centers
  • 5.3.3 Other End Users
• 5.4 Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 South Korea
    • 5.4.3.5 Australia
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Arthrex Inc.
  • 6.3.2 B. Braun Melsungen AG
  • 6.3.3 Cardinal Health Inc.
  • 6.3.4 CONMED Corporation
  • 6.3.5 Johnson & Johnson (DePuy Synthes)
  • 6.3.6 Orthofix Medical Inc.
  • 6.3.7 Medtronic plc
  • 6.3.8 Smith & Nephew plc
  • 6.3.9 Stryker Corporation
  • 6.3.10 Zimmer Biomet Holdings Inc.
  • 6.3.11 Invibio Ltd
  • 6.3.12 Globus Medical Inc.
  • 6.3.13 Acumed LLC
  • 6.3.14 Wright Medical Group N.V.
  • 6.3.15 NuVasive Inc.
  • 6.3.16 MicroPort Orthopedics Inc.
  • 6.3.17 OsteoMed LLC
  • 6.3.18 Integra LifeSciences Holdings Corp.
  • 6.3.19 Bio-Medical Enterprises Inc.
  • 6.3.20 Orthopaedic Implant Company

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment